Sex Spray To Get You In The Mood
Little squirt, little sniff and then your libido does a little cartwheel. Interesting concept, eh? Of course we don't know *yet* that any of this works... that's why they're testing it.
Okay, the full story doesn't run until 11pm Thursday (tonite) but I know enough of you check out this blog before that so I'll going to give you the Cliff Notes version as fast as possible.
Researchers in Seattle are testing a nasal spray and researchers here in Portland are testing a pill to see if either improve a woman's libido. And they need volunteers.
Wow. Pretty fast. Of course tonite's story has MUCH more detail.
If you want to get involved in the OHSU study of the pill call: 503.494.3666.
The pharmaceutical company that wants to market the pill if it works sent me this:
Hypoactive Sexual Desire Disorder (HSDD), a condition in which patients
suffer from their Decreased Sexual Desire, is the most common form of
Female Sexual Dysfunction. It is an important and defined medical
condition that can be identified and diagnosed.
The disorder is defined as diminished feelings of sexual interest or desire
and loss of sexual thoughts/fantasies that causes marked distress or
interpersonal difficulties.
Therefore, it can adversely impact a woman’s everyday activities,
adversely impact her relationship and lead to emotional isolation.
To help female patients who suffer from decreased sexual desire,
flibanserin is being developed by Boehringer Ingelheim as an oral daily
treatment.
Flibanserin is a molecule acting on the central nervous system and is not
a hormone product. It must be emphasised that this is not a “female
Viagra” because of its different indication and mechanism of action. The
product is being developed only for women with distress associated with
their Decreased Sexual Desire. Decreased Sexual Desire without any
related distress cannot be considered a disorder.
The aim of flibanserin is to restore a women’s sexual desire back to a
level she is comfortable with.
The product is in advanced clinical development for the treatment of premenopausal
women suffering from Decreased Sexual Desire.
It is currently being investigated in a phase III clinical trial program that will
involve about 5,000 women, expected to be completed in 2008. After
detailed evaluation, the registration process may be started.
And here's more on the nasal spray which researchers are looking at up in Seattle:
http://www.bremolanotide.com/
And, if you want to know what goes on in our bedrooms ((I'm really not setting you up for an inappropriate joke))... check out this link:
http://www.cdc.gov/nchs/nsfg.htm
Who knew the government studied this kind of stuff?!
HI MARK AND DAVE!! :-) Thanks for having me in the studio today. ((If this makes no sense see my video blog that I posted previously.))
Oh yeah, Mary was cool with me posting this picture with actress Missy Pyle.
